← Evidence map

ArticleNeoplasia (New York, N.Y.)2016

Corrigendum to "A Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non-Small Cell Lung Cancer Cells" [Neoplasia 18 (2016) 199-212].

Chi-Wei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Corrigendum to "A Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non-Small Cell Lung Cancer Cells" [Neoplasia 18 (2016) 199-212]. | OpenQuestion